Skip to main content
Clinical Trials/NCT02008435
NCT02008435
Completed
Not Applicable

Increasing the Effectiveness of the Diabetes Prevention Program Through If-then Plans and Mental Practice: A Parallel Randomized Trial

McGill University1 site in 1 country172 target enrollmentApril 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Overweight
Sponsor
McGill University
Enrollment
172
Locations
1
Primary Endpoint
Percent body weight loss
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The Diabetes Prevention Program (DPP) is highly effective in promoting weight loss in overweight and obese individuals (e.g., 7% average loss of body weight), and thereby reducing the risk of developing weight-related health consequences. One-on-one DPP sessions, however, are costly and the group-delivered DPP version, the Group Lifestyle Balance program (GLB), is less effective (4% average loss of body weight). The aim of this two-arm parallel randomized controlled trial is to increase the effectiveness of the GLB by integrating habit formation techniques, namely if-then plans and their mental practice, into the program. The study will provide evidence-based data on the effectiveness of an enhanced GLB intervention in promoting weight loss and in reducing weight-related risk factors for chronic health problems.

Detailed Description

Please see brief summary.

Registry
clinicaltrials.gov
Start Date
April 2013
End Date
December 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Barbel Knauper

Associate Professor

McGill University

Eligibility Criteria

Inclusion Criteria

  • men and women
  • ages of 18 and 75
  • overweight or obese (BMI 28-45 kg/m2)
  • sedentary (\< 200 min/week of moderate or vigorous exercise)
  • waist circumference of \>= 88cm for women and \>= 102cm for men

Exclusion Criteria

  • diabetes (hemoglobin A1c \< 7.0%).
  • taking the medication metformin (used for treating pre-diabetes or diabetes)
  • having been pregnant in the past 6 months or planning on becoming pregnant in the next 2 years
  • currently undergoing treatment for cancer
  • using medication that affects body weight (e.g., loop diuretics)
  • being unable to participate in regular moderate physical activity
  • having severe uncontrolled hypertension (\> 190/100mm Hg)
  • being unable to communicate in English or French
  • being diagnosed with bulimia nervosa, currently active major depression, or other severe psychiatric disease (including dementia);
  • suffering from a heart attack, stroke, or heart failure within the past 6 months

Outcomes

Primary Outcomes

Percent body weight loss

Time Frame: 3 months after beginning of the intervention

The primary outcome will be percent body weight loss from baseline to 3 months after the beginning of the intervention. Weight in kg.

Secondary Outcomes

  • Exercise stress test (EST)(3 months)
  • Personal exercise goal(24 months)
  • Total cholesterol/HDL ratio(24 months)
  • Number of steps taken per week(24 months)
  • Percent body weight loss(24 months)
  • Personal weight loss goal(24 months)
  • Hemoglobin A1c levels(24 months)
  • Physical activity duration(24 months)
  • Waist circumference(24 months)
  • Blood pressure(24 months)

Study Sites (1)

Loading locations...

Similar Trials